NYSEARCA:SBIO ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News $40.23 -0.53 (-1.30%) (As of 11/13/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesHoldingsOwnershipRatings About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SBIO alerts:Sign Up Key Stats Today's Range$40.23▼$41.3150-Day Range$36.06▼$42.4352-Week Range$24.54▼$42.73Volume24,797 shsAverage Volume10,376 shsMarket Capitalization$128.73 millionAssets Under Management$124.68 millionDividend Yield0.21%Net Expense Ratio0.50%Aggregate RatingModerate Buy ETF OverviewThe ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.Read More… Musk’s $130M Bet on Trump Pays Off Big (Ad)With Musk's deep ties to the new administration, xAI could soon leapfrog its rivals to become the dominant player in the AI space. And here's the kicker: we've found a backdoor investment opportunity to ride this wave of innovation before the rest of the market catches on.Click here to discover the company behind Musk's AI revolution. ALPS Medical Breakthroughs ETF ExpensesTypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.57%0.55%0.51%0.52%Other Expenses0.00%0.30%0.49%0.58%0.53%Total Expense0.50%0.70%0.71%0.73%0.71%Fee Waiver0.00%-0.45%-0.52%-0.67%-0.57%Net Expense0.50%0.61%0.61%0.58%0.59% Receive SBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address SBIO ETF News HeadlinesAdvacam & Vector Space Biosciences sign Letter of Intent (LOI) to Develop AI Models & CubeSat Payloads for the Space IndustryOctober 10, 2024 | businesswire.comWhy Biotech ETFs Are Beating the MarketSeptember 7, 2024 | msn.comIs AI Hype Hiding the Big Picture?Jeff Bezos has loaded up on a tiny company being called "the Next Nvidia." If you've never heard of what I call "QaaS" technology, you need to see this now.November 14, 2024 | InvestorPlace (Ad)ALPS Medical Breakthroughs ETF (^SBIO-IV)July 19, 2024 | finance.yahoo.comHow does spaceflight lead to medical breakthroughs? Veteran astronaut explainsMay 22, 2024 | msn.comALPS Medical Breakthroughs ETF (SBIO)April 17, 2024 | finance.yahoo.comSee More Headlines SBIO ETF - Frequently Asked Questions How have SBIO shares performed this year? ALPS Medical Breakthroughs ETF's stock was trading at $32.94 at the beginning of 2024. Since then, SBIO stock has increased by 22.1% and is now trading at $40.2291. View the best growth stocks for 2024 here. Who are ALPS Medical Breakthroughs ETF's major shareholders? Top institutional investors of ALPS Medical Breakthroughs ETF include International Assets Investment Management LLC (5.14%), Griffin Asset Management Inc. (0.94%) and McGuire Investment Group LLC (0.25%). How do I buy shares of ALPS Medical Breakthroughs ETF? Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of ALPS Medical Breakthroughs ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Waste Connections (WCN), American Water Works (AWK), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM). Fund Details IssuerALPS Fund NameALPS Medical Breakthroughs ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SBIO Inception Date12/31/2014 Fund ManagerRyan Mischker, Andrew Hicks WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS-Network Medical Breakthroughs Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings107 Fund Statistics Assets Under Management$124.68 million Average Daily Volume$9,774.20 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorALPS Fund Services, Inc. AdvisorALPS Advisors, Inc. CustodianState Street Bank and Trust Company DistributorALPS Portfolio Solutions Distributor, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerGTS Options OptionableN/A Short Interest7,700 shs Miscellaneous Outstanding Shares3,200,000Beta1.08 Creation Unit50,000 Creation Fee$500.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Top 10 SBIO HoldingsCorcept Therapeutics (NASDAQ:CORT)Holding Weight: 3.46%Avidity Biosciences (NASDAQ:RNA)Holding Weight: 3.33%Krystal Biotech (NASDAQ:KRYS)Holding Weight: 3.28%Arcellx (NASDAQ:ACLX)Holding Weight: 3.05%Alkermes (NASDAQ:ALKS)Holding Weight: 2.96%Crinetics Pharmaceuticals (NASDAQ:CRNX)Holding Weight: 2.87%Immunovant (NASDAQ:IMVT)Holding Weight: 2.84%Denali Therapeutics (NASDAQ:DNLI)Holding Weight: 2.51%Merus (NASDAQ:MRUS)Holding Weight: 2.27%Xenon Pharmaceuticals (NASDAQ:XENE)Holding Weight: 2.05%Full Holdings DetailsSBIO Sector ExposureSBIO Industry Exposure This page (NYSEARCA:SBIO) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
